Depemokimab-ulaa (Exdensur) has been approved by the US FDA as add-on maintenance therapy for severe asthma with an ...
The most pronounced increase in pathology tests is seen among children aged 6-11 years, where allergy testing volumes grew ...
US FDA approves GSK’s Exdensur for the treatment of severe asthma: London, UK Thursday, December 18, 2025, 11:00 Hrs [IST] GSK plc announced that the US Food and Drug Administra ...
Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life's chemistry, today announced that the US ...
Ibeh, a Nigerian doctoral candidate at the Texas A&M School of Public Health, tells BIODUN BUSARI how research inspired by his work in Nigeria earned him an award from a leading US professional ...
Lung development begins during embryogenesis and continues after birth. It includes branching of airways, formation of ...
MedPage Today on MSN
The Promise of Biomarkers to Direct Chronic Spontaneous Urticaria Therapy
Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...
News-Medical.Net on MSN
Lung immune cells switch roles to drive allergic inflammation
Alveolar macrophages are immune cells that live in the tiny air sacs of the lungs. Under normal conditions, these cells act ...
GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...
Objective This study aimed to explore health professionals’ perspectives on the management of preschool wheeze, including ...
Intense pain during a bowel movement sent our son to the ER. He got diagnosed with a blood clot in a hemorrhoid and needed surgery to fix it.
Acute systemic inflammation has long been suspected to trigger harmful processes within the brain, contributing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results